No Data
No Data
Maxim Group Initiates Virios Therapeutics(VIRI.US) With Buy Rating, Announces Target Price $1
Maxim Group analyst Jason McCarthy initiates coverage on $Virios Therapeutics(VIRI.US)$ with a buy rating, and sets the target price at $1.According to TipRanks data, the analyst has a success rate of
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with Avegant to develop optimized waveguide optical modules for
Virios Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/20/2024 305.84% Maxim Group → $1 Initiates Coverage On → Buy 09/20/2022 — HC Wainwright & Co. Downgrad
Express News | Virios Therapeutics Inc : Maxim Group Initiates Coverage With Buy Rating; Target Price $1
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results.G-III Apparel Group posted adjusted earn
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersMyMD Pharmaceuticals (NASDAQ:MYMD) stock rose 46.0% to $2.89 during Thursday's after-market session. The market value of their outstanding shares is at $6.6 million. Adaptimmune Therapeutics (N
No Data